The 10 minute talk was focused on how phosphorycholine receptors, CD36 and platelet activating factor receptor (PAFR), are necessary for the development of house dust mite allergy. Dr. Patel’s work demonstrates that IgM antibodies to phosphorylcholine can inhibit the uptake of house dust mite by these PC receptors on antigen-presenting cells in the lung to prevent the development of allergic disease. Her hope is that these types of findings will lead to the development of better therapeutics for the prevention of allergic disease.
Dr. Patel is a recent graduate of the UAB Graduate Biomedical Sciences Program and works in the lab of Dr. John Kearney. Other students from UAB to present included Sarah Dulson (Harrington Lab), Stacey Harbour (Weaver Lab) and Mohamed Khass (Schroeder Lab).
The Max D. Cooper Endowed Immunology Travel Award was established by the family of Max D. Cooper, M.D. to recognize his extraordinary accomplishments as professor of medicine, pediatrics, microbiology, and pathology and as Director of the Division of Developmental and Clinical Immunology at UAB. Carson Moseley, a MSTP student (Weaver lab) was recently awarded the Max D. Cooper Endowed Immunology Travel Award for 2016. He will be attending the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Conference in Paris in October 2017.
Dr. Patel is a recent graduate of the UAB Graduate Biomedical Sciences Program and works in the lab of Dr. John Kearney. Other students from UAB to present included Sarah Dulson (Harrington Lab), Stacey Harbour (Weaver Lab) and Mohamed Khass (Schroeder Lab).
The Max D. Cooper Endowed Immunology Travel Award was established by the family of Max D. Cooper, M.D. to recognize his extraordinary accomplishments as professor of medicine, pediatrics, microbiology, and pathology and as Director of the Division of Developmental and Clinical Immunology at UAB. Carson Moseley, a MSTP student (Weaver lab) was recently awarded the Max D. Cooper Endowed Immunology Travel Award for 2016. He will be attending the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Conference in Paris in October 2017.